First-ever cannabinoid anxiety relief education study (C.A.R.E.S) will explore CBD and cannabis efficacy to anxiety aggravated by COVID-19

9/23/20–The Cannabinoid Anxiety Relief Education Study (C.A.R.E.S.) will reach millions of CBD and cannabis users across the U.S. to assess the potential role of cannabinoids in reducing anxiety and other co-morbid conditions, such as insomnia and depression. This large-scale research study is especially relevant given high COVID-19 driven anxiety levels nationwide and the many state and local governments which have deemed cannabis businesses “essential” and thus accessible during this time. Read